Innoviva Stock Price Prediction
| INVA Stock | USD 17.41 0.14 0.80% |
Oversold Vs Overbought
32
Oversold | Overbought |
Quarterly Earnings Growth (0.98) | EPS Estimate Next Quarter 0.32 | EPS Estimate Current Year 0.425 | EPS Estimate Next Year 1.715 | Wall Street Target Price 19 |
Using Innoviva hype-based prediction, you can estimate the value of Innoviva from the perspective of Innoviva response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Innoviva to buy its stock at a price that has no basis in reality. In that case, they are not buying Innoviva because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Innoviva after-hype prediction price | USD 17.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Innoviva |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innoviva's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innoviva After-Hype Price Prediction Density Analysis
As far as predicting the price of Innoviva at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Innoviva or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Innoviva, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Innoviva Estimiated After-Hype Price Volatility
In the context of predicting Innoviva's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Innoviva's historical news coverage. Innoviva's after-hype downside and upside margins for the prediction period are 16.61 and 18.57, respectively. We have considered Innoviva's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Innoviva is very steady at this time. Analysis and calculation of next after-hype price of Innoviva is based on 3 months time horizon.
Innoviva Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Innoviva is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innoviva backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Innoviva, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 0.98 | 0.04 | 0.01 | 8 Events / Month | 8 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
17.41 | 17.59 | 0.23 |
|
Innoviva Hype Timeline
Innoviva is currently traded for 17.41. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of -0.01. Innoviva is anticipated to increase in value after the next headline, with the price projected to jump to 17.59 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.23%, whereas the daily expected return is currently at -0.16%. The volatility of related hype on Innoviva is about 1633.33%, with the expected price after the next announcement by competition of 17.40. The company reported the previous year's revenue of 310.46 M. Net Income was 179.72 M with profit before overhead, payroll, taxes, and interest of 276.11 M. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Innoviva Basic Forecasting Models to cross-verify your projections.Innoviva Related Hype Analysis
Having access to credible news sources related to Innoviva's direct competition is more important than ever and may enhance your ability to predict Innoviva's future price movements. Getting to know how Innoviva's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Innoviva may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORIC | Oric Pharmaceuticals | 0.04 | 8 per month | 0.00 | (0.07) | 5.15 | (5.60) | 20.53 | |
| LYRA | Lyra Therapeutics | 0.01 | 4 per month | 0.00 | (0.05) | 10.53 | (10.00) | 41.07 | |
| INBX | Inhibrx | (0.23) | 5 per month | 0.00 | (0.02) | 4.72 | (3.49) | 11.96 | |
| EPIX | ESSA Pharma | (0.03) | 9 per month | 0.00 | (0.1) | 8.70 | (5.90) | 84.25 | |
| SNSE | Sensei Biotherapeutics | 0.00 | 4 per month | 7.39 | 0.04 | 11.11 | (13.21) | 110.76 | |
| NXTC | NextCure | (0.05) | 5 per month | 0.00 | (0.18) | 5.43 | (7.75) | 24.13 | |
| NUVB | Nuvation Bio | 0.01 | 9 per month | 4.01 | 0.06 | 9.48 | (7.12) | 21.30 | |
| GLUE | Monte Rosa Therapeutics | (0.33) | 7 per month | 4.28 | 0.07 | 8.40 | (8.46) | 103.72 | |
| DSGN | Design Therapeutics | 0.19 | 5 per month | 5.71 | 0.06 | 8.54 | (8.79) | 33.11 | |
| ERAS | Erasca Inc | (0.21) | 7 per month | 0.00 | (0.02) | 6.06 | (5.40) | 20.29 |
Innoviva Additional Predictive Modules
Most predictive techniques to examine Innoviva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Innoviva using various technical indicators. When you analyze Innoviva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Innoviva Predictive Indicators
The successful prediction of Innoviva stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Innoviva, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Innoviva based on analysis of Innoviva hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Innoviva's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Innoviva's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 22.61 | 23.7 | 25.25 | 28.92 | Receivables Turnover | 3.54 | 5.17 | 3.69 | 3.51 |
Story Coverage note for Innoviva
The number of cover stories for Innoviva depends on current market conditions and Innoviva's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Innoviva is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Innoviva's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Innoviva Short Properties
Innoviva's future price predictability will typically decrease when Innoviva's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Innoviva often depends not only on the future outlook of the potential Innoviva's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Innoviva's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 86.9 M | |
| Cash And Short Term Investments | 193.5 M |
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |